A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease

Lu Zhang, Yu-han Gao, Si-yuan Li,Hao Zhao,Miao-yan Zhang,Yan-ying Yu, Yan-ting Liu,Jian Li

International Journal of Hematology(2024)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要